Skip to content

A randomised study to assess the efficacy of nasojejeunal verses nasogastric enteral feeding in critically ill patients during ICU stay.

Efficacy of nasojejeunal enteral feeding in critically ill patients.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000570684
Enrollment
50
Registered
2005-09-30
Start date
2003-09-05
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

This study examines the area of enteral feeding in critically ill patients. Current standard enteral feeding practice is via a naso-gastric tube with the addition of prokinetic agents for patients who fail to absorb their enteral nutrition. This study compares the efficacy of nasojejunal enteral feeding with naso-gastric enteral feeding with the addition of prokinetic agents. The duration of enteral feeding will be determined by the patient's nutritional requirements and their general condition

This study examines the area of enteral feeding in critically ill patients. Current standard enteral feeding practice is via a naso-gastric tube with the addition of prokinetic agents for patients who fail to absorb their enteral nutrition. This study compares the efficacy of nasojejunal enteral feeding with naso-gastric enteral feeding with the addition of prokinetic agents. The duration of enteral feeding will be determined by the patient's nutritional requirements and their general condition. However, data will be collected for duration of enteral feeding, 28 days or ICU discharge, whichever occurs first.

Sponsors

Intensive Care Unit, RMH
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients admitted to the ICU with an expected stay of more than 48h. 2. Patients commenced on enteral feeding via nasogastric route who fail to tolerate gastric feeding due to excessive gastric aspirate volumes. 3. Patients who consent or if the patient is incompetent, the next-of-kin who consent, to inclusion in the study.

Exclusion criteria

1. Patients aged less than 18 years.2. Patients with a known allergy to promotility agents, metoclopramide or erythromycin.3. Patients with a contra-indication to nasojejunal feeding.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026